Publications

Hansen AE, Gutte H, Holst P, Johannesen HH, Rahbek S, Clemmensen AE, Larsen MME, Schøier C, Ardenkjaer-Larsen J, Klausen TL, Kristensen AT, Kjaer A. Combined hyperpolarized 13C-pyruvate MRS and 18F-FDG PET (hyperPET) estimates of glycolysis in canine cancer patients. Eur J Radiol. 2018 Jun;103:6-12. doi: 10.1016/j.ejrad.2018.02.028. Epub 2018 Feb 25. PMID: 29803387. Link to article here

Kurbegovic S, Juhl K, Chen H, Qu C, Ding B, Leth JM, Drzewiecki KT, Kjaer A, Cheng Z. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery. Bioconjug Chem. 2018 Nov 21;29(11):3833-3840. doi: 10.1021/acs.bioconjchem.8b00669. Epub 2018 Oct 23. PMID: 30296054; PMCID: PMC6363276. Link to article here

Skovgaard D, Persson M, Brandt-Larsen M, Christensen C, Madsen J, Klausen TL, Holm S, Andersen FL, Loft A, Berthelsen AK, Pappot H, Brasso K, Kroman N, Højgaard L, Kjaer A. Safety, Dosimetry, and Tumor Detection Ability of 68Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging. J Nucl Med. 2017 Mar;58(3):379-386. doi: 10.2967/jnumed.116.178970. Epub 2016 Sep 8. PMID: 27609788. Link to article here

Loft MD, Sun Y, Liu C, Christensen C, Huang D, Kjaer A, Cheng Z. Improved positron emission tomography imaging of glioblastoma cancer using novel 68Ga-labeled peptides targeting the urokinase-type plasminogen activator receptor (uPAR). Amino Acids. 2017 Jun;49(6):1089-1100. doi: 10.1007/s00726-017-2407-4. Epub 2017 Mar 18. PMID: 28316028. Link to article here

Hansen AE, Andersen FL, Henriksen ST, Vignaud A, Ardenkjaer-Larsen JH, Højgaard L, Kjaer A, Klausen TL. Simultaneous PET/MRI with (13)C magnetic resonance spectroscopic imaging (hyperPET): phantom-based evaluation of PET quantification. EJNMMI Phys. 2016 Dec;3(1):7. doi: 10.1186/s40658-016-0143-6. Epub 2016 Apr 22. PMID: 27102632; PMCID: PMC4840180. Link to article here

Christensen A, Juhl K, Persson M, Charabi BW, Mortensen J, Kiss K, Lelkaitis G, Rubek N, von Buchwald C, Kjær A. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model. Oncotarget. 2017 Feb 28;8(9):15407-15419. doi: 10.18632/oncotarget.14282. PMID: 28039488; PMCID: PMC5362495. Link to article here